- 专利标题： Salicylic acid derivatives, pharmaceutically acceptable salt thereof, composition thereof and method of use thereof
-
申请号： US14550293申请日： 2013-05-24
-
公开(公告)号： US09650399B2公开(公告)日： 2017-05-16
- 发明人: Patrick Thomas Gunning , Sina Haftchenary , Brent David George Page , Samuel Weiss , Hema Artee Luchman , Melissa L. Fishel
- 申请人： The Governing Council of the University of Toronto , UTI Limited Partnership , Indiana University Research and Technology Corporation
- 申请人地址： CA Toronto, Ontario CA Calgary, Alberta US IN Indianapolis
- 专利权人： The Governing Council of the University of Toronto,UTI Limited Partnership,Indiana University Research and Technology Corporation
- 当前专利权人： The Governing Council of the University of Toronto,UTI Limited Partnership,Indiana University Research and Technology Corporation
- 当前专利权人地址： CA Toronto, Ontario CA Calgary, Alberta US IN Indianapolis
- 代理机构： Faegre Baker Daniels LLP
- 国际申请： PCT/US2013/042689 WO 20130524
- 国际公布： WO2013/177534 WO 20131128
- 主分类号： C07D233/84
- IPC分类号： C07D233/84 ; C07D215/36 ; C07C311/19 ; C07C311/21 ; A61K31/18 ; A61K31/625 ; C07F9/40 ; C07F9/38
摘要：
The present invention relates to novel compounds, compositions containing same and methods for inhibiting STAT3 and/or STAT5 activity or for the treatment of a STAT3 or STAT5-dependent cancer using said compounds; or a pharmaceutically acceptable salt, solvate or prodrug thereof.
公开/授权文献
信息查询
